Bioperl Unveils Version 1.4

Most bioinformatics programs churn out raw text files bursting with data, but devoid of interpretation. Programmers spend much of their time slogging through these files-computationally speaking – to extract useful information. For nearly 10 years, the bioperl project http://www.bioperl.org has labored to relieve bioinformaticians of this burden, building an object-oriented toolkit that handles the nitty gritty of data format and access so that developers can concentrate on their bioinform

Written byJeffrey Perkel
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Most bioinformatics programs churn out raw text files bursting with data, but devoid of interpretation. Programmers spend much of their time slogging through these files-computationally speaking – to extract useful information. For nearly 10 years, the bioperl project http://www.bioperl.org has labored to relieve bioinformaticians of this burden, building an object-oriented toolkit that handles the nitty gritty of data format and access so that developers can concentrate on their bioinformatics problems instead.

With modules to parse data files, communicate with databases, and call external programs, data pipelining is an obvious application. But a graphics engine also allows developers to render data visually. In fact, that engine powers the genome browser embedded in both the FlyBase and WormBase databases.

Bioperl version 1.4 adds support for new file formats, scalable vector graphics, restriction enzyme analyses, ontologies, population genetics, and RNAi, among others. It also features greatly improved documentation and "how to" files, says ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies